SN
Satyapal Nagendra Shukla
About Satyapal Nagendra Shukla
Data last updated:
Satyapal Nagendra Shukla is a Director at Globerian Pharma Private Limited (since 2024). The company operates in Chemicals. Globerian Pharma Private Limited reported revenue of ₹2.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Globerian Pharma Private Limited U24290HR2022PTC107872 | Director | 08 Jan 2024 | 2022 | ₹2.75 Cr (FY 2025) | Active |
Board colleagues of Satyapal Nagendra Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Chhokar | 09798093 | Globerian Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyapal Nagendra Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyapal Nagendra Shukla
Satyapal Nagendra Shukla currently holds 1 directorship: Globerian Pharma Private Limited (Director, since 08 Jan 2024, revenue ₹2.75 Cr (FY 2025)).
Satyapal Nagendra Shukla was first appointed on 08 Jan 2024 as Director at Globerian Pharma Private Limited.
The current boards of Satyapal Nagendra Shukla's companies include Anil Chhokar (Globerian Pharma Private Limited).